SCHEMBL13289360

SCHEMBL13289360

Bc1cnn2c(NCCCCNC(=O)Nc3cc(Cl)ccc3OC)cc(-c3ccccc3Cl)nc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ HTR3E A5X5Y0 1/20 0.44
▸ HTR3B O95264 1/20 0.44
▸ HTR3A P46098 1/20 0.44
▸ HTR3D Q70Z44 1/20 0.44
▸ HTR3C Q8WXA8 1/20 0.44
▸ GAA P10253 1/20 0.43
▸ KMT2A Q03164 7/20 0.43
▸ MEN1 O00255 6/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ CCR3 P51677 1/20 0.43
▸ IGF1R P08069 1/20 0.42
▸ HDAC3 O15379 2/20 0.41
▸ HDAC4 P56524 2/20 0.41
▸ HDAC1 Q13547 2/20 0.41
▸ HDAC7 Q8WUI4 2/20 0.41
▸ HDAC2 Q92769 2/20 0.41
▸ HDAC10 Q969S8 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13289559 0.95 ALDH1A1 (0.48) ALDH1A1CYP1A2CYP2C19HTR3EHTR3B
SCHEMBL13121840 0.92 GSK3B (0.51) ALDH1A1CYP1A2CYP2C19HTR3EHTR3B
SCHEMBL13121921 0.87 GSK3B (0.53) ALDH1A1CYP1A2CYP2C19HTR3EHTR3B
SCHEMBL13121815 0.85 GSK3B (0.55) ALDH1A1HTR3EHTR3BHTR3AHTR3D
SCHEMBL13288948 0.84 BRD4 (0.45) ALDH1A1KMT2AMEN1L3MBTL1HDAC3
SCHEMBL13289584 0.83 MEN1 (0.44) ALDH1A1CYP2C19KMT2AMEN1TP53
SCHEMBL13288682 0.81 GSK3B (0.44) ALDH1A1CYP1A2CYP2C19KMT2AMEN1
SCHEMBL13289235 0.81 CDK2 (0.45) ALDH1A1KMT2AHDAC3HDAC1GSK3B
SCHEMBL13288952 0.81 CDK2 (0.44) KMT2AMEN1HDAC3HDAC1MAPT
SCHEMBL13289322 0.80 GSK3B (0.46) ALDH1A1KMT2AMAPTGSK3BCDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2194058-A1 Pyrazolopyrimidines suitable for the treatment of cancer diseases SCHERING CORPORATION (US) 2010-06-09 — — EP disclosed
Send feedback